Determination of the Persistence of Non-Spore-Forming Biological Threat Agents in the Environment
U.S. Environmental Protection Agency, Office of Research and Development, National Homeland Security Research Center. 12/07/2015This 35-page report presents the results of an investigation to evaluate the persistence (or natural attenuation) of Yersinia pestis (Y. pestis), Francisella tularensis (F. tularensis), and Burkholderia mallei (B. mallei) on glass and soil under multiple environmental conditions and time points. This generation of scientifically defensible persistence data is useful for the proper planning of decontamination efficacy tests and for formulation of response or remediation plans in preparation for pos...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 17, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news
SURVEILLANCE SUMMARIES: Melioidosis Cases and Selected Reports of Occupational Exposures to Burkholderia pseudomallei — United States, 2008–2013
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 3, 2015 Category: American Health Source Type: news
Escape of dangerous bacterium leads to halt of risky studies at Tulane
Leak of Burkholderia pseudomallei has led to intense search for source, newspaper reports (Source: ScienceNOW)
Source: ScienceNOW - March 2, 2015 Category: Science Source Type: news
Baby Wipes Company Nutek Disposables Issues Recall After Possible Contamination
(Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 27, 2014 Category: Consumer Health News Source Type: news
Letter to the Editors
In the article entitled “Sniff the Plates? Laboratory Exposure to Burkholderia pseudomallei” in the February 15, 2013 issue of Clinical Microbiology Newsletter (CMN Vol. 35, No. 4), Knost et al. () reported a case of melioidosis in a 27-year-old-male. After reading the article, we note the need for a number of clarifications that we would like to bring to the attention of the CMN readership. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - April 28, 2014 Category: Microbiology Authors: Tina J. Benoit, David D. Blaney Tags: Letter to the Editors Source Type: news
Communication Between Bacteria Helps Them Resist Antibiotics
New research from Western University unravels a novel means of communication that allows bacteria such as Burkholderia cenocepacia (B. cenocepacia) to resist antibiotic treatment. B. cenocepacia is an environmental bacterium that causes devastating infections in patients with cystic fibrosis (CF) or with compromised immune systems. Dr. Miguel Valvano and first author Omar El-Halfawy, PhD candidate, show that the more antibiotic resistant cells within a bacterial population produce and share small molecules with less resistant cells, making them more resistant to antibiotic killing... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 6, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
Bacteria communicate to help each other resist antibiotics
(University of Western Ontario) New research from Western University (Canada) unravels a novel means of communication that allows bacteria such as Burkholderia cenocepacia (B. cenocepacia) to resist antibiotic treatment. B. cenocepacia is an environmental bacterium that causes devastating infections in patients with cystic fibrosis. Dr. Miguel Valvano and first author Omar El-Halfawy, show that the more antibiotic resistant cells within a bacterial population produce and share small molecules with less resistant cells, making them more resistant to antibiotic killing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2013 Category: Global & Universal Source Type: news
Sniff the Plates? Laboratory Exposure to Burkholderia pseudomallei
We report a case of melioidosis in a 27-year-old male who presented with localized neck swelling and later developed complications due to the patient's non-compliance with his antibiotic therapy. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - February 6, 2013 Category: Microbiology Authors: S. Knost, M.C. Marroum, T. Nozar, L. Tagle, J. Horton, L.W. Raymond, J. Kase, S. Kilpatrick, W. Boehringer, A.Y. Peng, R.L. Sautter Source Type: news
Zicam Extreme Congestion Relief Nasal Gel: Recall—Contamination With Burkholderia Cepacia
Matrixx Initiatives notified the public of a recall of one lot of Zicam Extreme Congestion Relief nasal gel. Burkholderia cepacia was found in a single sample of the product taken from the affected lot. The problem was detected during a routine review at the manufacturing facility. Tests on additional samples from the same lot have shown no evidence of the organism. (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - December 19, 2012 Category: Complementary Medicine Authors: NCCAM Source Type: news
Cystic Fibrosis: Meveol effective against Burkholderia Dolosa
The new generation of antimicrobial confirmed its potential with the evidence of effectiveness on this resistant bacterium kindly provided by Harvard Children's Hospital for which no therapeutic solution is available to date
Apr 07, 2011 – Alaxia, a Lyons biotech that is developing the candidate drug Meveol hired an independent certified laboratory to confirm in vitro efficacy recorded by its microbiologists. The effect of Meveol has been studied on several strains of Burkholderia dolosa. Meveol bactericidal efficacy - over 99.9% - is observed in a few hours.
These results were obtained as part of a research partnersh...
Source: Alaxia - April 7, 2011 Category: Respiratory Medicine Source Type: news
Efficacy also shown on Mycobacteria for Meveol
Further to some clinician request, Alaxia ordered an independant lab, CER in Belgium, to test Meveol efficacy vs atypical mycobacteria. Meveol shows high efficacy vs this strong pathogenic strain.
We remind you Meveol is effective not only on Pseudomonas but on wide spectrum of bacteria including positive and negative gram Burkholderia, Pseudomonas even in biofilm form. (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - June 28, 2010 Category: Respiratory Medicine Source Type: news
A new tool for Cystic Fibrosis
Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - March 27, 2009 Category: Respiratory Medicine Source Type: news
A new tool for Cystic Fibrosis
Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia) (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - March 27, 2009 Category: Respiratory Medicine Source Type: news
A new tool for Cystic Fibrosis
Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia) (Source: Alaxia) (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - March 27, 2009 Category: Respiratory Medicine Source Type: news
